This page shows the latest Voluntis news and features for those working in and with pharma, biotech and healthcare.
France-headquartered digital therapeutics company Voluntis has entered a collaboration with pharma giant Bristol-Myers Squibb to co-develop digital therapeutics for oncology. ... The deal is centred on Voluntis’ Theraxium Oncology software platform,
The Digital Therapeutics Alliance’s founding members include Akili and Voluntis. A new organisation that aims to help move digital therapeutics into the medical mainstream by broadening their understanding, adoption, and ... Pierre Leurent, CEO at
Also joining the PCHAlliance are France’s Voluntis, a therapeutic companion software firm working with Sanofi in diabetes, and the Danish Health Data Authority.
Voluntis focuses on ‘embedding connectivity in therapeutics and medical intelligence in software’ and last year gained FDA clearance and the European CE mark for the new mobile app. ... The long-term alliance we have with Voluntis will help us to
More from news
Approximately 3 fully matching, plus 1 partially matching documents found.
The company has a number of partnerships in place, notably with companion software company Voluntis around its Diabeo diabetes app, though it quietly announced the termination of its drug-device research
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...